BROOKFIELD CORP - BNCN 6.089 PERP (BN-PR-Z.CA) Fundamental Analysis & Valuation

TSX:BN-PR-Z • CA11271J8260

Current stock price

25.54 CAD
-0.05 (-0.2%)
Last:

This BN-PR-Z.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. BN-PR-Z.CA Profitability Analysis

1.1 Basic Checks

  • In the past year BN-PR-Z was profitable.
  • BN-PR-Z had a positive operating cash flow in the past year.
  • In the past 5 years BN-PR-Z has always been profitable.
  • In the past 5 years BN-PR-Z always reported a positive cash flow from operatings.
BN-PR-Z.CA Yearly Net Income VS EBIT VS OCF VS FCFBN-PR-Z.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B 20B

1.2 Ratios

  • BN-PR-Z has a worse Return On Assets (0.22%) than 75.00% of its industry peers.
  • Looking at the Return On Equity, with a value of 2.38%, BN-PR-Z is doing worse than 72.37% of the companies in the same industry.
  • BN-PR-Z's Return On Invested Capital of 3.12% is on the low side compared to the rest of the industry. BN-PR-Z is outperformed by 69.74% of its industry peers.
  • BN-PR-Z had an Average Return On Invested Capital over the past 3 years of 3.45%. This is significantly below the industry average of 8.84%.
Industry RankSector Rank
ROA 0.22%
ROE 2.38%
ROIC 3.12%
ROA(3y)0.17%
ROA(5y)0.38%
ROE(3y)1.84%
ROE(5y)3.62%
ROIC(3y)3.45%
ROIC(5y)3.35%
BN-PR-Z.CA Yearly ROA, ROE, ROICBN-PR-Z.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 4 6 8 10

1.3 Margins

  • The Profit Margin of BN-PR-Z (1.52%) is worse than 71.05% of its industry peers.
  • In the last couple of years the Profit Margin of BN-PR-Z has declined.
  • With a Operating Margin value of 27.21%, BN-PR-Z is not doing good in the industry: 60.53% of the companies in the same industry are doing better.
  • BN-PR-Z's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 37.98%, BN-PR-Z perfoms like the industry average, outperforming 42.11% of the companies in the same industry.
  • BN-PR-Z's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 27.21%
PM (TTM) 1.52%
GM 37.98%
OM growth 3Y17.08%
OM growth 5Y10.73%
PM growth 3Y-9.6%
PM growth 5YN/A
GM growth 3Y-3.12%
GM growth 5Y-2.91%
BN-PR-Z.CA Yearly Profit, Operating, Gross MarginsBN-PR-Z.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. BN-PR-Z.CA Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, BN-PR-Z has less shares outstanding
  • BN-PR-Z has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, BN-PR-Z has an improved debt to assets ratio.
BN-PR-Z.CA Yearly Shares OutstandingBN-PR-Z.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
BN-PR-Z.CA Yearly Total Debt VS Total AssetsBN-PR-Z.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100B 200B 300B 400B 500B

2.2 Solvency

  • BN-PR-Z has a Debt/Equity ratio of 5.42. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 5.42, BN-PR-Z is doing worse than 88.16% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 5.42
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
BN-PR-Z.CA Yearly LT Debt VS Equity VS FCFBN-PR-Z.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50B 100B 150B 200B 250B

2.3 Liquidity

  • A Current Ratio of 1.14 indicates that BN-PR-Z should not have too much problems paying its short term obligations.
  • BN-PR-Z's Current ratio of 1.14 is on the low side compared to the rest of the industry. BN-PR-Z is outperformed by 71.05% of its industry peers.
  • BN-PR-Z has a Quick Ratio of 1.00. This is a normal value and indicates that BN-PR-Z is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of BN-PR-Z (1.00) is worse than 71.05% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1
BN-PR-Z.CA Yearly Current Assets VS Current LiabilitesBN-PR-Z.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. BN-PR-Z.CA Growth Analysis

3.1 Past

  • The earnings per share for BN-PR-Z have decreased strongly by -17.63% in the last year.
  • The earnings per share for BN-PR-Z have been decreasing by -14.72% on average. This is quite bad
  • The Revenue for BN-PR-Z has decreased by -12.68% in the past year. This is quite bad
  • The Revenue has been growing slightly by 3.66% on average over the past years.
EPS 1Y (TTM)-17.63%
EPS 3Y-14.72%
EPS 5YN/A
EPS Q2Q%-53.96%
Revenue 1Y (TTM)-12.68%
Revenue growth 3Y-6.8%
Revenue growth 5Y3.66%
Sales Q2Q%3.76%

3.2 Future

  • The Earnings Per Share is expected to grow by 30.46% on average over the next years. This is a very strong growth
  • BN-PR-Z is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.44% yearly.
EPS Next Y35.94%
EPS Next 2Y29.98%
EPS Next 3Y30.46%
EPS Next 5YN/A
Revenue Next Year55.61%
Revenue Next 2Y34.78%
Revenue Next 3Y18.44%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BN-PR-Z.CA Yearly Revenue VS EstimatesBN-PR-Z.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20B 40B 60B 80B
BN-PR-Z.CA Yearly EPS VS EstimatesBN-PR-Z.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

6

4. BN-PR-Z.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 8.57, the valuation of BN-PR-Z can be described as reasonable.
  • Compared to the rest of the industry, the Price/Earnings ratio of BN-PR-Z is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Earnings ratio of 27.47, BN-PR-Z is valued rather cheaply.
  • The Price/Forward Earnings ratio is 6.30, which indicates a rather cheap valuation of BN-PR-Z.
  • BN-PR-Z's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BN-PR-Z is cheaper than 75.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of BN-PR-Z to the average of the S&P500 Index (22.62), we can say BN-PR-Z is valued rather cheaply.
Industry RankSector Rank
PE 8.57
Fwd PE 6.3
BN-PR-Z.CA Price Earnings VS Forward Price EarningsBN-PR-Z.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • BN-PR-Z's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BN-PR-Z is cheaper than 63.16% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.38
BN-PR-Z.CA Per share dataBN-PR-Z.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • BN-PR-Z's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BN-PR-Z's earnings are expected to grow with 30.46% in the coming years.
PEG (NY)0.24
PEG (5Y)N/A
EPS Next 2Y29.98%
EPS Next 3Y30.46%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. BN-PR-Z.CA Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.61%, BN-PR-Z is not a good candidate for dividend investing.
  • BN-PR-Z's Dividend Yield is comparable with the industry average which is at 1.78.
  • With a Dividend Yield of 0.61, BN-PR-Z pays less dividend than the S&P500 average, which is at 1.81.
Industry RankSector Rank
Dividend Yield 0.61%

5.2 History

  • The dividend of BN-PR-Z decreases each year by -4.53%.
  • BN-PR-Z has paid a dividend for at least 10 years, which is a reliable track record.
  • As BN-PR-Z did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)-4.53%
Div Incr Years0
Div Non Decr Years7
BN-PR-Z.CA Yearly Dividends per shareBN-PR-Z.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 63.07% of the earnings are spent on dividend by BN-PR-Z. This is not a sustainable payout ratio.
DP63.07%
EPS Next 2Y29.98%
EPS Next 3Y30.46%
BN-PR-Z.CA Yearly Income VS Free CF VS DividendBN-PR-Z.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5B -10B
BN-PR-Z.CA Dividend Payout.BN-PR-Z.CA Dividend Payout, showing the Payout Ratio.BN-PR-Z.CA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

BN-PR-Z.CA Fundamentals: All Metrics, Ratios and Statistics

BROOKFIELD CORP - BNCN 6.089 PERP

TSX:BN-PR-Z (4/23/2026, 7:00:00 PM)

25.54

-0.05 (-0.2%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-12
Earnings (Next)05-14
Inst Owners59.94%
Inst Owner ChangeN/A
Ins Owners10.32%
Ins Owner ChangeN/A
Market Cap62.59B
Revenue(TTM)75.10B
Net Income(TTM)1.14B
Analysts76.84
Price Target32.17 (25.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.61%
Yearly Dividend0.42
Dividend Growth(5Y)-4.53%
DP63.07%
Div Incr Years0
Div Non Decr Years7
Ex-Date03-13
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-21.37%
Min EPS beat(2)-50.31%
Max EPS beat(2)7.58%
EPS beat(4)2
Avg EPS beat(4)-9.73%
Min EPS beat(4)-50.31%
Max EPS beat(4)7.58%
EPS beat(8)5
Avg EPS beat(8)5.51%
EPS beat(12)9
Avg EPS beat(12)6.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1086.71%
Min Revenue beat(2)1057%
Max Revenue beat(2)1116.42%
Revenue beat(4)4
Avg Revenue beat(4)1107.15%
Min Revenue beat(4)1057%
Max Revenue beat(4)1136.66%
Revenue beat(8)8
Avg Revenue beat(8)1117.85%
Revenue beat(12)12
Avg Revenue beat(12)745.97%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.64%
PT rev (3m)8.41%
EPS NQ rev (1m)-3.25%
EPS NQ rev (3m)-7.15%
EPS NY rev (1m)-2.23%
EPS NY rev (3m)-1.92%
Revenue NQ rev (1m)0.65%
Revenue NQ rev (3m)-9.41%
Revenue NY rev (1m)5.41%
Revenue NY rev (3m)-1.14%
Valuation
Industry RankSector Rank
PE 8.57
Fwd PE 6.3
P/S 0.61
P/FCF N/A
P/OCF 4.15
P/B 0.96
P/tB N/A
EV/EBITDA 9.38
EPS(TTM)2.98
EY11.67%
EPS(NY)4.05
Fwd EY15.86%
FCF(TTM)-5.6
FCFYN/A
OCF(TTM)6.15
OCFY24.09%
SpS41.89
BVpS26.71
TBVpS-18.94
PEG (NY)0.24
PEG (5Y)N/A
Graham Number42.3189 (65.7%)
Profitability
Industry RankSector Rank
ROA 0.22%
ROE 2.38%
ROCE 4.48%
ROIC 3.12%
ROICexc 3.23%
ROICexgc 3.97%
OM 27.21%
PM (TTM) 1.52%
GM 37.98%
FCFM N/A
ROA(3y)0.17%
ROA(5y)0.38%
ROE(3y)1.84%
ROE(5y)3.62%
ROIC(3y)3.45%
ROIC(5y)3.35%
ROICexc(3y)3.57%
ROICexc(5y)3.48%
ROICexgc(3y)4.42%
ROICexgc(5y)4.29%
ROCE(3y)4.95%
ROCE(5y)4.8%
ROICexgc growth 3Y-0.98%
ROICexgc growth 5Y5.08%
ROICexc growth 3Y-0.39%
ROICexc growth 5Y4.08%
OM growth 3Y17.08%
OM growth 5Y10.73%
PM growth 3Y-9.6%
PM growth 5YN/A
GM growth 3Y-3.12%
GM growth 5Y-2.91%
F-Score7
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 5.42
Debt/FCF N/A
Debt/EBITDA 8.43
Cap/Depr 202.96%
Cap/Sales 28.05%
Interest Coverage 1.41
Cash Conversion 35.79%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 1
Altman-Z N/A
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)203.84%
Cap/Depr(5y)222.75%
Cap/Sales(3y)23.66%
Cap/Sales(5y)22.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.63%
EPS 3Y-14.72%
EPS 5YN/A
EPS Q2Q%-53.96%
EPS Next Y35.94%
EPS Next 2Y29.98%
EPS Next 3Y30.46%
EPS Next 5YN/A
Revenue 1Y (TTM)-12.68%
Revenue growth 3Y-6.8%
Revenue growth 5Y3.66%
Sales Q2Q%3.76%
Revenue Next Year55.61%
Revenue Next 2Y34.78%
Revenue Next 3Y18.44%
Revenue Next 5YN/A
EBIT growth 1Y6.21%
EBIT growth 3Y9.11%
EBIT growth 5Y14.78%
EBIT Next Year135.85%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y32.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.97%
OCF growth 3Y7.37%
OCF growth 5Y5.69%

BROOKFIELD CORP - BNCN 6.089 PERP / BN-PR-Z.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BROOKFIELD CORP - BNCN 6.089 PERP (BN-PR-Z.CA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to BN-PR-Z.CA.


Can you provide the valuation status for BROOKFIELD CORP - BNCN 6.089 PERP?

ChartMill assigns a valuation rating of 6 / 10 to BROOKFIELD CORP - BNCN 6.089 PERP (BN-PR-Z.CA). This can be considered as Fairly Valued.


How profitable is BROOKFIELD CORP - BNCN 6.089 PERP (BN-PR-Z.CA) stock?

BROOKFIELD CORP - BNCN 6.089 PERP (BN-PR-Z.CA) has a profitability rating of 3 / 10.


What are the PE and PB ratios of BROOKFIELD CORP - BNCN 6.089 PERP (BN-PR-Z.CA) stock?

The Price/Earnings (PE) ratio for BROOKFIELD CORP - BNCN 6.089 PERP (BN-PR-Z.CA) is 8.57 and the Price/Book (PB) ratio is 0.96.


Can you provide the financial health for BN-PR-Z stock?

The financial health rating of BROOKFIELD CORP - BNCN 6.089 PERP (BN-PR-Z.CA) is 2 / 10.